BJCM
AGN

Blue Jay Capital Management’s Allergan plc AGN Stock Holding History

Blue Jay Capital Management’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-36,940
Closed -$8.54M – 23
2016
Q2 		$8.54M Buy
+36,940
New +$8.52M 5.61% 13

Other funds holding AGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Blue Jay Capital Management's AGN Position: Q3 2016 in Review

Blue Jay Capital Management sold out of Allergan plc (AGN) in Q3 2016, closing a stake of 36,940 shares — an estimated $8.54M sold.

Blue Jay Capital Management first reported a position in AGN in Q2 2016 and held it in 1 quarter. The position peaked at $8.54M in Q2 2016. 1,105 funds tracked by Wall St. Rank hold AGN as of Q3 2016.

  • Blue Jay Capital Management reported no remaining Allergan plc position as of Q3 2016 after selling out during the quarter.
  • Blue Jay Capital Management sold 36,940 Allergan plc shares in Q3 2016, an estimated $8.54M.
  • Blue Jay Capital Management first reported a position in Allergan plc in Q2 2016 and held it in 1 quarter.
  • Blue Jay Capital Management's Allergan plc position peaked at $8.54M in Q2 2016.
  • 1,105 funds tracked by Wall St. Rank held Allergan plc as of Q3 2016.

Based on Blue Jay Capital Management's 13F filing for Q3 2016, filed 10 Nov 2016.